(2S)-2-(2,5-dioxopyrrolidin-1-yl)-3-(1H-imidazol-5-yl)propanoic acid

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (2S)-2-(2,5-dioxopyrrolidin-1-yl)-3-(1H-imidazol-5-yl)propanoic acid
• 化学式: C₁₀H₁₁N₃O₄
• 分子量: 237.21
• InChiKey: CYMUEIUMPVJGCK-ZETCQYMHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.1
• 重原子数：
  17
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  103
• 氢给体数：
  2
• 氢受体数：
  5

文献信息

• N-ACYLIC AMINOACID DERIVATIVES. METHOD FOR THE PRODUCTION THEREOF, PHARMACOLOGICAL COMPOSITION AND THE USE IN THE FORM OF ANTI-ALLERGIC, ANTI-INFLAMMATORY AND HYPOLIPIDEMIC AGENTS
  申请人：Nebolsin, Vladimir Evgenievich

  公开号：EP1905763A1

  公开（公告）日：2008-04-02

  The present invention relates to N-acyl derivatives of amino acids and pharmaceutically acceptable salts thereof wherein n is 2 or 3; and R1 represents or pharmaceutically acceptable salts thereof, to novel processes for preparing the same, to use thereof as anti-allergic, anti-anaphylactic, anti-inflammatory and hypolipidemic agents as well as to a pharmaceutical composition comprising the indicated compounds in an efficient amount and to a method for treating allergic and inflammatory diseases and lipid metabolism disorders: bronchial asthma, allergic rhinitis, pollinoses, seasonal and year-round rhinitis, allergic pneumonitis, atopic dermatitis, psoriasis, urticaria, allergic (including anaphylactic) reactions to insect stings and medicaments, cold allergy, allergic conjunctivitis, atherosclerosis, obesity, ischemic heart and cerebral disease, myocardial infarction and stroke.

  本发明涉及氨基酸的 N-酰基衍生物及其药学上可接受的盐类 其中 n 是 2 或 3；以及 R1 代表 或其药学上可接受的盐；涉及制备上述物质的新工艺；涉及将上述物质用作抗过敏、抗过敏反应、抗炎症和降血脂药剂；涉及包含有效量的上述化合物的药物组合物；还涉及治疗过敏性和炎症性疾病以及脂质代谢紊乱的方法：支气管哮喘、过敏性鼻炎、花粉症、季节性和全年性鼻炎、过敏性肺炎、特应性皮炎、银屑病、荨麻疹、对昆虫叮咬和药物的过敏反应（包括过敏性反应）、寒冷过敏、过敏性结膜炎、动脉粥样硬化、肥胖、缺血性心脑疾病、心肌梗塞和中风。
• N-ACYLIC AMINOACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACOLOGICAL COMPOSITION AND THE USE IN THE FORM OF ANTI-ALLERGIC, ANTI-INFLAMMATORY AND HYPOLIPIDEMIC AGENTS
  申请人：Nebolsin, Vladimir Evgenievich

  公开号：EP1905763B1

  公开（公告）日：2019-05-08
• Use of peptides FOR THE TREATMENT OF THE COMPLICATIONS AND PATHOLOGY OF DIABETES
  申请人：Peptech Limited

  公开号：EP0666753B1

  公开（公告）日：2000-11-22
• METHOD FOR THE TREATMENT OF THE COMPLICATIONS AND PATHOLOGY OF DIABETES
  申请人：PEPTIDE TECHNOLOGY LTD

  公开号：EP0666753A1

  公开（公告）日：1995-08-16
• EP0666753A4
  申请人：——

  公开号：EP0666753A4

  公开（公告）日：1995-01-26